BioLamina AB is a Swedish AB based in Sundbyberg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2008, the company reported revenue of SEK 170.4m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet ska var att bedriva forskning, utveckling, produktion och försäljning inom biomedicin och bioteknik därmed förenlig verksamhet.
In its most recent annual report (2025), BioLamina AB reported revenue of SEK 170.4m, a decrease of 28% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 26.1m, and the EBITDA margin stood at -4.2%.
At the end of 2025, equity financed 34.8% of the balance sheet, and current assets covered short-term debt 5.5 times.
Frequently asked questions
What is the Org number of BioLamina AB?
BioLamina AB is registered with Bolagsverket / SCB under Org 5567641872.
What is the revenue of BioLamina AB?
BioLamina AB reported revenue of SEK 170.4m in 2025.
Who is the CEO of BioLamina AB?
Klaus Rudolf Langhoff-Roos is the CEO of BioLamina AB, in role since 2024.
Who is the chairman of BioLamina AB?
Sophie Ingrid Madeleine Hagströmer chairs the board of BioLamina AB, in role since 2021.
Where is BioLamina AB headquartered?
BioLamina AB's registered address is Löfströms Allé 5.
